Clinical Trials Logo

Clinical Trial Summary

At Wake Forest University, the investigators have been using Extended Release Epidural Morphine (EREM), since late 2004, as part of multimodal analgesia in patients having gynecologic surgeries and hip arthroplasties.

Hypothesis:

In patients undergoing a Birmingham total hip arthroplasty (BHA), low dose EREM in conjunction with lumbar plexus block (LPB) will be better than lumbar plexus block alone in increasing proportion of patients who meet discharge criteria within 24 hours.


Clinical Trial Description

Extended release epidural morphine (EREM, DepoDur®: Endo Pharmaceuticals, Chadds Ford PA) has been studied and increasingly utilized as a method to allow for the improved post-operative analgesia of epidural analgesia without infusions.

At Wake Forest University, the investigators have been using EREM, since late 2004, as part of multimodal analgesia in patients having gynecologic surgeries and hip arthroplasties. The investigators initially decreased our dosages from those recommended (15 mg for lower extremity surgery and 10-15 mg for abdominal surgery), because side effects (nausea, vomiting and hypotension) were felt to be limiting to recovery. The investigators now use 4-7.5 mg in most patients, with 7.5 mg being the exception and have achieved better results. For hip arthroplasties, the investigators currently use 4-5 mg and have performed two retrospective chart reviews on this use; both suggesting that this approach is efficacious. However, these doses have not been studied in a prospective, randomized, double blind trial. The investigators would like to evaluate the efficacy of this dose of EREM used as part of a multimodal regimen. The investigators will compare EREM 4 mg with lumbar plexus block versus lumbar plexus block alone, (providing the rest of our multimodal approach for both patients). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00934661
Study type Interventional
Source Wake Forest University Health Sciences
Contact
Status Terminated
Phase Phase 4
Start date January 2010
Completion date March 2013

See also
  Status Clinical Trial Phase
Completed NCT02275494 - The Influence of Leg Length Discrepancy After Total Hip Arthroplasty on Function and Quality of Life N/A
Completed NCT00967980 - Femoral Versus Psoas Continuous Peripheral Nerve Blocks Following Hip Arthroplasty Phase 4
Completed NCT03585647 - Anesthetic Methods and Gene Expression Profile
Not yet recruiting NCT06009432 - Efficacy of Proprioceptive Neuromuscular Facilitation Exercise Program in Total Hip Arthroplasty N/A
Completed NCT00921908 - Multihole or Epidural Catheter for Local Anesthetic in the Wound N/A
Completed NCT00367289 - CT for Diagnosis of Implant Stability in Revision Arthroplasty N/A
Completed NCT00253838 - A Comparison of Two Type of Stems in Revision Hip Arthroplasty N/A
Enrolling by invitation NCT04592939 - Trial of Weight Bearing Status Following Femoral Revision With Tapered, Fluted, Titanium Stems N/A
Not yet recruiting NCT03259672 - Influence of Sevoflurane and Desflurane on Postoperative Sore Throat N/A
Completed NCT00912873 - Optimizing Local Anesthetic Concentration for Continuous Lumbar Plexus Nerve Blocks Phase 4
Recruiting NCT05807828 - VR Simulation and Basic Skills in THA N/A
Terminated NCT00621530 - Effect of Spinal Ketorolac on Mechanical Hypersensitivity After a Total Hip Replacement Phase 2
Recruiting NCT04426058 - CMP vs Fascia Iliaca Block N/A
Terminated NCT02818764 - Delirium, Intraoperative Cerebral Perfusion and EEG Abnormalities After Total Hip Arthroplasty
Completed NCT00261040 - Minimally Invasive Surgery of the Hip Versus Standard Approach N/A
Completed NCT03173339 - Influence of Remifentanil on Postoperative Sore Throat in Patients Undergoing General Anesthesia N/A
Completed NCT03035435 - Fast-track Rehabilitation After Total Knee or Hip Arthroplasty N/A
Completed NCT01520961 - Functional Recovery After Partial Hip Arthroplasty: Anterior or Posterolateral Approach? N/A
Completed NCT00226070 - Rehabilitation to Patients Over 65 Years Undergoing THA Phase 1/Phase 2
Completed NCT04304287 - The Benefit of Autologous Blood Transfusion in Total Hip Arthroplasty N/A